Cadence Capital Management’s Pfizer PFE Stock Holding History

Cadence Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$2.82M	Sell	81,088 -21,895	-21%	-$768K	0.68%	31
2020 Q2	$3.19M	Sell	102,983 -11,333	-10%	-$385K	0.46%	36
2020 Q1	$3.54M	Buy	114,316 +14,718	+15%	+$502K	0.6%	21
2019 Q4	$3.7M	Buy	99,598 +10,111	+11%	+$360K	0.4%	49
2019 Q3	$3.05M	Buy	89,487 +2,738	+3%	+$99.6K	0.43%	58
2019 Q2	$3.56M	Sell	86,749 -67,573	-44%	-$2.68M	0.36%	55
2019 Q1	$6.22M	Sell	154,322 -115	-0.1%	-$4.61K	0.56%	31
2018 Q4	$6.4M	Sell	154,437 -211,825	-58%	-$8.79M	0.65%	24
2018 Q3	$15.3M	Sell	366,262 -26,482	-7%	-$1.02M	0.83%	12
2018 Q2	$13.5M	Sell	392,744 -2,791	-0.7%	-$95.4K	0.8%	19
2018 Q1	$13.3M	Buy	395,535 +12,515	+3%	+$430K	0.87%	12
2017 Q4	$13.2M	Sell	383,020 -13,039	-3%	-$445K	0.84%	18
2017 Q3	$13.4M	Buy	396,059 +19,717	+5%	+$634K	0.84%	17
2017 Q2	$12M	Sell	376,342 -16,840	-4%	-$531K	0.83%	21
2017 Q1	$12.8M	Sell	393,182 -16,440	-4%	-$518K	0.88%	18
2016 Q4	$12.6M	Buy	409,622 +32,541	+9%	+$993K	0.88%	14
2016 Q3	$12.1M	Buy	377,081 +34,948	+10%	+$1.17M	0.88%	19
2016 Q2	$11.4M	Sell	342,133 -63,146	-16%	-$2.02M	0.86%	29
2016 Q1	$11.4M	Sell	405,279 -19,722	-5%	-$563K	0.8%	39
2015 Q4	$13M	Buy	425,001 +23,198	+6%	+$730K	0.87%	32
2015 Q3	$12M	Sell	401,803 -66,703	-14%	-$2.14M	0.84%	32
2015 Q2	$14.9M	Buy	468,506 +79,338	+20%	+$2.59M	0.83%	20
2015 Q1	$12.8M	Sell	389,168 -48,843	-11%	-$1.55M	0.78%	20
2014 Q4	$12.9M	Sell	438,011 -77,527	-15%	-$2.22M	0.75%	34
2014 Q3	$14.5M	Buy	515,538 +80,901	+19%	+$2.27M	0.76%	25
2014 Q2	$12.2M	Buy	434,637 +33,621	+8%	+$958K	0.59%	16
2014 Q1	$12.2M	Sell	401,016 -39,953	-9%	-$1.19M	0.51%	25
2013 Q4	$12.8M	Sell	440,969 -39,620	-8%	-$1.15M	0.49%	41
2013 Q3	$13.1M	Buy	+480,589	New	+$13.1M	0.44%	20

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cadence Capital Management's PFE Position: Q3 2020 in Review

Cadence Capital Management reduced its Pfizer (PFE) stake by 21% in Q3 2020, selling an estimated $768K and leaving 81,088 shares worth $2.82M. The position accounts for 0.68% of the portfolio, ranked #31.

Cadence Capital Management first reported a position in PFE in Q3 2013 and has held it in 29 quarters since. The position peaked at $15.3M in Q3 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Cadence Capital Management held 81,088 shares of Pfizer worth $2.82M as of Q3 2020.
Cadence Capital Management sold 21,895 Pfizer shares in Q3 2020, an estimated $768K.
Pfizer made up 0.68% of Cadence Capital Management's portfolio in Q3 2020, its #31 holding.
Cadence Capital Management first reported a position in Pfizer in Q3 2013 and has held it in 29 quarters since.
Cadence Capital Management's Pfizer position peaked at $15.3M in Q3 2018.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.